Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone

Cancer Prevention and Control

Volumn 2, Issue 2, 1998, Pages 79-87

  Brundage, M D ^a   Crook, J M ^a   Lukka, H ^a   Klotz, L ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STRONTIUM 89;

BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DRUG EFFICACY; HUMAN; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT OUTCOME;

BONE MARROW; BONE NEOPLASMS; HUMANS; MALE; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; STRONTIUM RADIOISOTOPES;

EID: 0031954408     PISSN: 1206548X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)